<DOC>
	<DOCNO>NCT01401803</DOCNO>
	<brief_summary>The purpose study provide data assess Dysport™ injection treatment therapy brow ptosis . This study assess outcome brow lift use Dysport .</brief_summary>
	<brief_title>Brow Lifting With Dysport</brief_title>
	<detailed_description>One common reason patient present dermatologist plastic surgeon brow lid ptosis . Although patient present entity require surgery , decline surgical intervention . Alternative treatment include brow lift botulinum toxin . Brow lift botulinum toxin may perform inject muscle responsible brow lid depression . These muscle include : corrugators , procerus , medical aspect frontalis depressor component orbicularis oculi muscle . By relax muscle , brow elevator may able lift brow help brow lid ptosis . This trial unique utilizes Dysport treat entire anatomic muscle group ( brow depressor ) rather inject isolate muscles._</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Healthy male female subject race , 2575 year age Mild Moderate brow ptosis ( 2 3 5point Brow Positioning Grading Scale ) Subject sign IRBapproved Informed Consent Form Authorization Use Release Health Research Study Information ( HIPAA ) form prior studyrelated procedure perform Subject able follow study instruction likely complete require visit , assess Treating Investigator Subject urine pregnancy test evaluate negative* within 7 day prior plan study treatment , use contraception least month prior plan study treatment , agree use contraception duration study Subjects childbearing potential must negative urine pregnancy test result Baseline practice reliable method contraception throughout study : A female consider childbearing potential unless : postmenopausal &gt; 12 month prior study drug administration ; without uterus and/or ovary ; surgically sterile ( e.g. , tubal ligation ) &gt; 6 month prior study drug administration . The following method contraception , properly use , generally consider reliable female childbearing potential may participate study : hormonal contraceptives† ( oral , patch , injection , implant ) ; male condom intravaginal spermicide diaphragm cervical cap spermicide ; vaginal contraceptive ring ; intrauterine device ; surgical sterilization ( bilateral tubal ligation ) ; partner vasectomized†† ; total sexual abstinence* . Hormonal contraceptive must start least 90 day prior study drug administration , intrauterine contraceptive device must place least 30 day prior study drug administration . Vasectomized &gt; 3 month 0 sperm count ; * Female subject childbearing potential sexually active require practice reliable method contraception . They may enrol Investigator 's discretion provide counseled remain sexually inactive duration study understand possible risk involve get pregnant study . Previous injection botulinum toxin serotype within 6 month , Previous injection semipermanent filler upper face ( i.e . glabella , periorbital , temporal area ) within last 12 month . Previous injection permanent filler upper face ( i.e . glabella , periorbital , temporal area ) exclude Subjects pregnant ( positive urine pregnancy test ) , breastfeed , childbearing potential practicing reliable method birth control Subjects plan facial cosmetic procedure study period prior cosmetic procedure ( i.e. , surgery ) visible scar may affect evaluation response Facial asymmetry , ptosis , excessive dermatochalasis , deep dermal scarring , thick sebaceous skin , inability substantially lessen upper facial rhytids even physically spread apart Previous cosmetic surgery upper face ( e.g. , periorbital surgery , brow lift , eyelid eyebrow surgery , etc . ) Laser resurfacing , soft tissue augmentation periocular area 12months precede Visit 1 Medical condition may increase risk exposure botulinum toxin include diagnose Myasthenia Gravis , EatonLambert Syndrome , Amyotrophic Lateral Sclerosis , disease might interfere neuromuscular function Current use aminoglycoside antibiotic , curarelike agent , agent might interfere neuromuscular ( skeletal ) function Profound atrophy/excessive weakness muscle target area injection History facial nerve palsy Any patient know autoimmune disease compromise immune system ie HIV , AIDS current chemotherapy Infection injection site systemic infection ( case , postpone study entry one week follow recovery ) Allergy sensitivity component Dysport™ Evidence recent alcohol drug abuse Medical and/or psychiatric problem severe enough interfere study result ( Investigator opinion ) History poor cooperation , noncompliance medical treatment , unreliability Exposure investigational drug study within 30 day Baseline Visit</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>periorbital</keyword>
	<keyword>glabella</keyword>
	<keyword>ptosis</keyword>
	<keyword>eyelid</keyword>
	<keyword>brow</keyword>
</DOC>